Effect of treatment of overt hypothyroidism on insulin resistance
Open Access
- 1 January 2013
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 4 (4) , 157-61
Abstract
To investigate the impact of hypothyroidism and thyroxine therapy on insulin sensitivity in patients with overt hypothyroidism. The study included twenty seven overtly hypothyroid and fifteen healthy euthyroid South Western Asian females. Both groups had matching age and body mass index. Physiological and pathological conditions as well as medications that may alter thyroid function, glucose homeostasis or serum lipids were ruled out. Serum thyrotropin (TSH), free tetraiodothyronine (FT4), free triiodothyronine (FT3), fasting insulin (FI), fasting plasma glucose (FPG), total cholesterol and triglycerides were measured before and six months after initiating thyroxine therapy for hypothyroid patients and once for the control group. Insulin resistance (IR) was estimated using homeostasis model assessment (HOMA-IR) and Body mass index (BMI) was calculated. Both study groups, hypothyroid patients and euthyroid control subjects, had matching age and body mass index (P-value 0.444, 0.607 respectively). No significant difference was found between the hypothyroid patients and the euthyroid control group regarding fasting plasma glucose, fasting insulin, insulin resistance, total cholesterol and triglycerides (P-values 0.432, 0.621, 0.883, 0.586, 0.05 respectively). In the hypothyroid patients, triglycerides showed direct correlation to TSH and inverse correlation to FT3. Similarly total cholesterol inversely correlated to FT3 but its direct correlation to TSH did not reach statistical significance. After thyroxine replacement and reaching an euthyroid state as confirmed by clinical and laboratory data, there was no significant change in fasting plasma glucose, insulin resistance or triglyceride level (P-value 0.216, 0.204, 0.175 respectively) while total cholesterol significantly decreased (P-value 0.043) and fasting insulin significantly increased (P-value 0.047). Hypothyroidism has no impact on insulin sensitivity. Correction of hypothyroidism is not associated with a significant change of insulin sensitivity or triglycerides, but with a significant reduction of total cholesterol.Keywords
This publication has 39 references indexed in Scilit:
- Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)Clinical Endocrinology, 2008
- Lipoprotein Alterations, Hepatic Lipase Activity, and Insulin Sensitivity in Subclinical Hypothyroidism: Response to L-T 4 TreatmentThyroid®, 2007
- Subclinical Hypothyroidism is Associated with Insulin Resistance in Rheumatoid ArthritisThyroid®, 2004
- Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid ratsInternational Journal of Obesity, 2001
- Changes in Lipoprotein(a) Levels in Overt and Subclinical Hypothyroidism Before and During TreatmentThyroid®, 2000
- Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapyClinical Nutrition, 1999
- The Influence of Hypo- and Hyperthyreosis on Insulin Receptors and MetabolismArchives of Physiology and Biochemistry, 1999
- The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and EClinical Endocrinology, 1997
- Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual ScreeningDiabetic Medicine, 1995
- Selective Measurement of Two Lipase Activities in Postheparin Plasma from Normal Subjects and Patients with HyperlipoproteinemiaJournal of Clinical Investigation, 1974